Minocycline ameliorates cognitive impairment in rats with trigeminal neuralgia by regulating microglial polarization
International Immunopharmacology · 2025
DOI: 10.1016/j.intimp.2024.113786 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Immunopharmacology, 2025. Verfasst von Junjie Li und 9 weiteren Autor:innen. Beteiligte Einrichtung: School of Basic Medical Sciences, Ningxia Medical University, Yinchuan 750004, China. Hauptthemen laut MEDLINE: Minocycline, Microglia, Cognitive Dysfunction, Trigeminal Neuralgia. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 66 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: National Natural Science Foundation of China, Ningxia Medical University, Ningxia Hui Autonomous Region Natural Science Foundation.
Abstract (Originalsprache)
Trigeminal neuralgia (TN)-related cognitive impairment is a common cause of decreased quality of life in patients and is closely associated with neuroinflammation. Although minocycline has demonstrated anti-inflammatory, analgesic, and neuroprotective functions, its role in treating TN-related cognitive impairment remains unreported. In this study, we used an in vivo TN model and an in vitro model of primary microglial neuroinflammation to investigate the potential effects of minocycline on cognitive function and microglial polarization in TN rats. Our results suggested that minocycline treatment attenuated cognitive deficits by alleviating hippocampal neuronal damage and enhancing synaptic plasticity in TN rats. Furthermore, both in vitro and in vivo assays demonstrated that minocycline polarized activated microglia to the M2 phenotype, leading to the reduction of pro-inflammatory factors, including tumor necrosis factor-α and interleukin-1, and an increase in the anti-inflammatory factors, such as interleukin-4 and interleukin-10, thereby attenuating neuroinflammation. Moreover, it was found that the TLR4/MyD88/NF-κB pathway was involved in the shift of microglia from a pro-inflammatory (M1) to an anti-inflammatory (M2). In summary, minocycline likely mediated the process of microglia polarization partly via the TLR4/MyD88/NF-κB pathway, promoting neuronal survival and restoring synaptic plasticity, thereby improving TN-related cognitive impairment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Basic Medical Sciences, Ningxia Medical University, Yinchuan 750004, China.
- School of Stomatology, Ningxia Medical University, Yinchuan 750004, China.
- School of Basic Medical Sciences, Ningxia Medical University, Yinchuan 750004, China; General Hospital of Ningxia Medical University, Yinchuan, Ningxia 750004, China. Electronic address: 20070001@nxmu.edu.cn.
Förderung
- National Natural Science Foundation of China
- Ningxia Medical University
- Ningxia Hui Autonomous Region Natural Science Foundation
Zitieren
APA
Li, J., Mi, X., Yang, Z., Feng, Z., Han, Y., Wang, T., Lv, H., Liu, Y., Wu, K., & Liu, J. (2025). Minocycline ameliorates cognitive impairment in rats with trigeminal neuralgia by regulating microglial polarization. International Immunopharmacology. https://doi.org/10.1016/j.intimp.2024.113786
Vancouver
Li J, Mi X, Yang Z, Feng Z, Han Y, Wang T, et al. Minocycline ameliorates cognitive impairment in rats with trigeminal neuralgia by regulating microglial polarization. International Immunopharmacology. 2025. doi:10.1016/j.intimp.2024.113786
BibTeX
@article{Li2025,
author = {Li, Junjie and Mi, Xiaojuan and Yang, Zhilun and Feng, Ziqi and Han, Yong and Wang, Ting and Lv, Haowen and Liu, Yanbo and Wu, Kang and Liu, Juan},
title = {Minocycline ameliorates cognitive impairment in rats with trigeminal neuralgia by regulating microglial polarization},
journal = {International Immunopharmacology},
year = {2025},
doi = {10.1016/j.intimp.2024.113786}
}
EUVIMED